gracecast - are there treatment options for patients with her-2 nsclc
Published 3 years ago • 30 plays • Length 5:59Download video MP4
Download video MP3
Similar videos
-
6:31
gracecast - treatment options for patients with advanced nsclc and a her2- erbb2 mutation
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
9:49
gracecast - treatment options for patients with nsclc and high tumor pd-l1 expression
-
6:56
gracecast - leading treatment options for patients with negative tumor pd-l1 nsclc with dr. stephen
-
9:18
gracecast - treatment options for metastatic nsclc
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
9:41
gracecast- asco lung 2020- enhertu and the potential for treatment of her2 positive nsclc
-
15:54
gracecast-075_lung-cancer_ccilc - optimal treatment for stage iiia n2 node-positive nsclc
-
5:35
gracecast - what is the optimal treatment for patients with advanced nsclc and a braf-v600e mutation
-
1:59:57
grace - global resource for advancing cancer education live stream
-
6:29
case based panel discussion nsclc – does a positive her2 mutation effect treatment decisions?
-
6:52
gracecast - lcvl - leading treatment options for patients with low or negative tumor pd-l1 expressio
-
3:26
what are some local therapy options for patients with nsclc? - targeted therapies in lung cancer
-
10:18
treatments and study data for patients with alk nsclc - targeted therapies in lung cancer 2023
-
14:59
gracecast-074_lung-cancer_ccilc - adjuvant therapy for smaller node-negative nsclc
-
10:43
gracecast-007_lung-cancer_optimal treatment of unresectable locally advanced nsclc
-
14:17
gracecast-032_lung-cancer_intro to first line nsclc treatment
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023